Fortunato et al. reported that PD-L1+ CSCs in non-small cell lung cancer are able to specifically increase the percentage of Tregs in culture, and this effect could be abrogated by CXCR4 inhibitors 74. Here, CD274 is linked to non-small cell lung carcinoma.